Skip to Content
Cancer Helpline
800.227.2345
Live Chat
Sign Up For Email
American Cancer Society
  • Español
  • More Languages
Give In Honor & Memorial Donate
Give In Honor & Memorial Donate
  • Cancer A-Z
  • Stay Healthy
  • Treatment & Support
  • News
  • Our Research
  • Get Involved
  • Our Partners
  • About Us
Cancer Helpline
800.227.2345
Live Chat
Sign Up For Email
Search
Category
En Español

Latest News

Our team of expert journalists brings you all angles of the cancer story – from breaking news and survivor stories to in-depth insights into cutting-edge research.

Filtering by:

Bladder Cancer
Top Story
April 16, 2019

FDA Approves First Targeted Therapy for Bladder Cancer

The US Food and Drug Administration (FDA) has approved Balversa (erdafitinib) as the first targeted therapy for bladder cancer.

Bladder Cancer, Cancer Updates, FDA, Targeted Therapy
Share
Facebook Twitter
Read More
July 10, 2018

Study: Outcomes Similar for Robotic vs. Traditional Bladder Cancer Surgery

Surgeons at 15 medical centers in the US have compared the outcomes of robotic surgery to traditional open surgery for bladder cancer. The study found outcomes to be similar for both types of surgery.

Bladder Cancer, Cancer Updates, Surgery
Share
Facebook Twitter
May 30, 2017

Bladder and Breast Cancer Survivor Finds Road To Recovery

The third time Judy Halter heard the words, “You have cancer,” she panicked. “I knew there was a possibility that my time here could definitely be shortened,” she said. But even more than her diagnosis of bladder cancer, Halter says she worried about how she was going to get to treatment.

Bladder Cancer, Breast Cancer, Michigan, Stories of Hope, Survivorship
Share
Facebook Twitter
May 24, 2017

FDA Approves Keytruda (Pembrolizumab) for Any Tumor with Specific Genetic Change

The US Food and Drug Administration (FDA) has expanded the approval of the immunotherapy drug Keytruda (pembrolizumab) to include tumors with a specific genetic change regardless of cancer type.

Bladder Cancer, Cancer Updates, Colon and Rectal Cancer, Endometrial Cancer, FDA, Gastrointestinal Cancers, Head and Neck Cancer, Hodgkin Lymphoma, Immunotherapy, Lung Cancer, Skin Cancer
Share
Facebook Twitter
May 10, 2017

FDA Approves Bavencio (Avelumab) for Bladder Cancer

The US Food and Drug Administration (FDA) has approved the immunotherapy drug Bavencio (avelumab) to treat people with advanced urothelial carcinoma, the most common type of bladder cancer.

Bladder Cancer, Cancer Updates, FDA, Immunotherapy
Share
Facebook Twitter
May 2, 2017

FDA Approves Imfinzi (Durvalumab) for Bladder Cancer

The US Food and Drug Administration (FDA) has approved the immunotherapy drug Imfinzi (durvalumab) to treat people with advanced urothelial carcinoma, the most common type of bladder cancer.

Bladder Cancer, Cancer Updates, FDA, Immunotherapy
Share
Facebook Twitter
Read More
December 26, 2016

New Cancer Drug Approvals From 2016

In 2016, the FDA approved several new drug treatments for different cancer types that American Cancer Society editors believe will make a significant difference.

Bladder Cancer, Chemotherapy, Chronic Lymphocytic Leukemia (CLL), Head and Neck Cancer, Hodgkin Lymphoma, Immunotherapy, Living Well, Lung Cancer, Soft Tissue Sarcoma, Targeted Therapy
Share
Facebook Twitter
November 11, 2016

CDC: 40% of Cancer Cases in US Might Be Linked to Tobacco

New data from the Centers for Disease Control and Prevention (CDC) show that 40% of cancers diagnosed in the US may have a link to tobacco use.

Acute Myeloid Leukemia (AML), Bladder Cancer, Cancer Updates, Cervical Cancer, Colon and Rectal Cancer, Esophageal Cancer, Kidney Cancer, Laryngeal and Hypopharyngeal Cancer, Liver Cancer, Lung Cancer, Oral Cavity and Oropharyngeal Cancer, Pancreatic Cancer, Smoking Tobacco, Stomach Cancer
Share
Facebook Twitter
Load More Results
Latest News
Cancer Updates
Living Well
ACS Research
Stories of Hope
Special Coverage

Featured Topics

Breast CancerVaccinationsColon and Rectal Cancer
  • Cancer Topics
  • Cancer Types

More Cancer News

read more
Cancer Facts and Statistics

Get the most current information about cancer

read more
Dr. Len's Blog

Perspectives on cancer news from our deputy chief medical officer

Read More
ACS Press Room

Our one-stop-shop for the media

BackTo Top

Imagine a world free from cancer. Help make it a reality.

DONATE

Cancer Information

  • Cancer Prevention & Detection
  • Cancer Basics
  • Signs & Symptoms of Cancer
  • Treatments & Side Effects
  • Cancer Facts & Statistics
  • News and Stories
  • Glossary
  • For Health Care Professionals

Programs & Services

  • Breast Cancer Support
  • TLC Hair Loss & Mastectomy Products
  • Hope Lodge® Lodging
  • Rides To Treatment
  • Online Support Communities

ACS FUNDRAISERS

  • Making Strides Against Breast Cancer Walks
  • Relay For Life Events
  • College Relay For Life
  • Coaches vs. Cancer
  • Galas, Balls & Parties
  • Ways to Give
  • Memorial Giving
  • Planned Giving
  • Leadership Giving
  • Donate a Car

About ACS

  • Contact Us
  • Local Offices
  • Employment
  • Information for Suppliers
  • Report Fraud or Abuse
  • Global Health
  • ACS CAN
  • Sign Up for Email
  • Policies
  • Our Volunteers

More ACS Sites

  • Bookstore
  • Cancer Atlas
  • Press Room
  • Cancer Statistics Center
  • Volunteer Learning Center

Follow Us

Twitter Facebook Instagram

Cancer Information, Answers, and Hope. Available Every Minute of Every Day.

800.227.2345

Live Chat

Follow Us

Twitter Facebook Instagram
  • help
  • site map
  • privacy policy - 2018
  • accessibility
  • terms of use
  • state fundraising notices
  • Site Comments

© 2019 American Cancer Society, Inc. All rights reserved. The American Cancer Society is a qualified 501(c)(3) tax-exempt organization. Cancer.org is provided courtesy of the Leo and Gloria Rosen family.

*
Image of
Previous Next
Close

Select A Hope Lodge

Close
Woman in black scarf facing camera
Your help makes breakthrough research, free rides to treatment, free places to stay near hospitals, and other crucial patient services all possible.
$50
$75
$125

Other

$
Donate

Your gift is 100% tax deductible

No, Thanks